|
|
Volumn 333, Issue 6051, 2011, Pages 1813-
|
|
Public health - Experts debate polypill: A single pill for global health
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHOLESTEROL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FOLIC ACID;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CARDIOVASCULAR DISEASE;
DRUG DEVELOPMENT;
DRUG PRESCRIBING;
GLOBAL PERSPECTIVE;
HEALTH RISK;
MEDICINE;
PUBLIC HEALTH;
SPATIAL ANALYSIS;
WESTERN WORLD;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
DIET;
EXERCISE;
HUMAN;
LOW DRUG DOSE;
OBESITY;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PILL;
POLYPILL;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
SCREENING;
SHORT SURVEY;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 80053347718
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.333.6051.1813 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|
